Market Research Logo

Czech Republic Pharmaceuticals & Healthcare Q1 2019

Czech Republic Pharmaceuticals & Healthcare Q1 2019

Key View:

Czech Republic will continue to post positive growth over our forecast period with regard to defence expenditure asregional security threats, namely Russian assertiveness in Eastern Europe and the ongoing refugee crisis, continue to simmer.Cementing this expenditure growth will be the country's positive economic outlook, with Czech Republic among the most stableeconomies in emerging Europe. Expenditure will predominantly be directed at continued force modernisation and procurement,and although the domestic industry will receive some investment for development, we do not expect indigenous capabilities tomake any significant leaps forwards - although an uptick in technology transfers and cooperation agreements poses upside risk tothis view.


Key View
SWOT
Pharmaceuticals & Healthcare SWOT
Industry Forecast
Pharmaceutical Market Forecast
Healthcare Market Forecast
Prescription Drug Market Forecast
Patented Drug Market Forecast
Generic Drug Market Forecast
OTC Medicine Market Forecast
Pharmaceutical Trade Forecast
Industry Risk/Reward Index
Central And Eastern Europe Innovative Pharmaceuticals Risk/Reward Index
Czech Republic Innovative Pharmaceuticals Risk/Reward Index
Regulatory Development
Regulatory Review
Market Overview
Competitive Landscape
Company Profile
Zentiva
Czech Republic Demographic Outlook
Pharmaceuticals & Healthcare Glossary
Pharmaceuticals & Healthcare Methodology

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Share this report